News

News Room

2024.01.09

China's First! Neuboron's Domestic Boron Drug Approved for IND Clinical Trials
News
Neuboron Pioneers BNCT Technology Advancement and Drives Novel Boron Drug Transformation through Academic-Industry Collaboration

2023.12.13

2329
News
Neuboron's NeuPex AB-BNCT System Approved for the "Green Channel" Special Review Process by the NMPA to Drive Commercialization for a Novel Targeted Radiotherapy Modality

2023.08.15

3702
News
Sino-Italian BNCT Workshop Staged to Bolster Collaboration in Boron Neutron Capture Therapy (BNCT)

2023.08.14

3509
News
Neuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at Xiamen BNCT Tech Forum to Drive Clinical Application and New Drug Development

2023.05.09

4350
News
China Performs First Cancer Patient Treatments in the Xiamen Humanity Hospital Using Novel Accelerator-based Radiation Oncology Therapy (BNCT)

2023.01.31

4703
News
In China for Global: Enhance the global image in the BNCT Society --- Prof. Liu Yuan-Hao accepted an exclusive interview with the ISNCT

2022.08.30

4590
News
Neuboron Medtech starts animal pre-clinical study after successfully installed its BNCT system NeupexTM in China’s first BNCT Center

2022.03.25

4380
News
Happy 2022 and everything goes well

2021.12.31

4804
News
Neuboron Medical Group: Government-enterprise strategic cooperation to accelerate the clinical development of boron neutron capture therapy(BNCT) in China

2021.11.10

5544
News
Neuboron Medical Group's cutting-edge Boron Neutron Capture Therapy（BNCT） product were presented at the ICNCT-19 conference

2021.10.01

5737
News
The Xiamen BNCT Center and Neuboron BNCT Group

2021.09.07

5662
News
Rainer Gunzelmann, Partner of Wuesthoff & Wuesthoff，presides as the honorary international chief IP consultant of Neuboron Medtech since 2021

2021.03.19

6377
News
China’s First BNCT Center Makes Debut

2021.02.09

5039
News
Neuboron Medtech, a BNCT total solution provider, enters Joint-Venture Agreement with TAE Life Sciences, further consolidating Neuboron’s global influence

2020.12.09

5745

Events

News Room

China's First! Neuboron's Domestic Boron Drug Approved for IND Clinical Trials

Neuboron Pioneers BNCT Technology Advancement and Drives Novel Boron Drug Transformation through Academic-Industry Collaboration

Neuboron's NeuPex AB-BNCT System Approved for the "Green Channel" Special Review Process by the NMPA to Drive Commercialization for a Novel Targeted Radiotherapy Modality

Sino-Italian BNCT Workshop Staged to Bolster Collaboration in Boron Neutron Capture Therapy (BNCT)

Neuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at Xiamen BNCT Tech Forum to Drive Clinical Application and New Drug Development

China Performs First Cancer Patient Treatments in the Xiamen Humanity Hospital Using Novel Accelerator-based Radiation Oncology Therapy (BNCT)

In China for Global: Enhance the global image in the BNCT Society --- Prof. Liu Yuan-Hao accepted an exclusive interview with the ISNCT

Neuboron Medtech starts animal pre-clinical study after successfully installed its BNCT system NeupexTM in China’s first BNCT Center

Happy 2022 and everything goes well

Neuboron Medical Group: Government-enterprise strategic cooperation to accelerate the clinical development of boron neutron capture therapy(BNCT) in China

Neuboron Medical Group's cutting-edge Boron Neutron Capture Therapy（BNCT） product were presented at the ICNCT-19 conference

The Xiamen BNCT Center and Neuboron BNCT Group

Rainer Gunzelmann, Partner of Wuesthoff & Wuesthoff，presides as the honorary international chief IP consultant of Neuboron Medtech since 2021

China’s First BNCT Center Makes Debut

Neuboron Medtech, a BNCT total solution provider, enters Joint-Venture Agreement with TAE Life Sciences, further consolidating Neuboron’s global influence